Search research articles
Contact Us
Filters
Showing results (21-30 of 94) with videos related to
Page
of 10
Sort By:
Clinical Therapeutics
|
December 22, 2005
Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
Phil McEwan, Keshwar Baboolal, Pete Conway, et al.
Current Medical Research and Opinion
|
September 8, 2017
Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema
Sarah E Holden, Craig J Currie, David R Owens
Diabetologia
|
June 4, 2014
Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs
Sarah E Holden, Christian A Bannister, Craig J Currie
BMC Musculoskeletal Disorders
|
November 6, 2008
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study
Chris D Poole, Pete Conway, Alan Reynolds, et al.
Current Medical Research and Opinion
|
January 6, 2006
Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)
Phil McEwan, John R Peters, Klas Bergenheim, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2004
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate
Marc Evans, Phil McEwan, John R Peters, et al.
Current Medical Research and Opinion
|
December 21, 2018
Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials
Sarah E Holden, Barry Kapik, Annette B Beiderbeck, et al.
Pharmacoeconomics
|
February 1, 2006
Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
Phil McEwan, Simon Dixon, Keshwar Baboolal, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 25, 2014
Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo
Chris D Poole, Mark P Connolly, Jane Chang, et al.
Current Medical Research and Opinion
|
September 8, 2017
Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes
Craig J Currie, Sarah E Holden, Ellen Berni, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 94) with videos related to
Sort By:
Page
of 10
Clinical Therapeutics
|
December 22, 2005
Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
Phil McEwan, Keshwar Baboolal, Pete Conway, et al.
Current Medical Research and Opinion
|
September 8, 2017
Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema
Sarah E Holden, Craig J Currie, David R Owens
Diabetologia
|
June 4, 2014
Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs
Sarah E Holden, Christian A Bannister, Craig J Currie
BMC Musculoskeletal Disorders
|
November 6, 2008
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study
Chris D Poole, Pete Conway, Alan Reynolds, et al.
Current Medical Research and Opinion
|
January 6, 2006
Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)
Phil McEwan, John R Peters, Klas Bergenheim, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2004
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate
Marc Evans, Phil McEwan, John R Peters, et al.
Current Medical Research and Opinion
|
December 21, 2018
Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials
Sarah E Holden, Barry Kapik, Annette B Beiderbeck, et al.
Pharmacoeconomics
|
February 1, 2006
Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
Phil McEwan, Simon Dixon, Keshwar Baboolal, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 25, 2014
Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo
Chris D Poole, Mark P Connolly, Jane Chang, et al.
Current Medical Research and Opinion
|
September 8, 2017
Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes
Craig J Currie, Sarah E Holden, Ellen Berni, et al.
Page
of 10